Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors), PAF receptor antagonists(Platelet activating factor receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC31H37ClN2O8S |
InChIKeyLZVBMKDVEPGGFK-ISIPKWIHSA-N |
CAS Registry193739-23-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Phase 2 | PL | - | - |
Dermatitis, Atopic | Phase 2 | - | - | |
Dermatitis, Atopic | Phase 2 | - | - | |
Dermatitis, Atopic | Phase 2 | US | - | - |
Psoriasis | Phase 2 | - | - | - |
Psoriasis | Phase 2 | US | - | - |
Psoriasis | Phase 2 | - | - | |
Psoriasis | Phase 2 | - | - | |
Respiratory Distress Syndrome, Adult | Phase 2 | US | - | - |
Skin Diseases | Phase 2 | JP | - | - |